Penta will spend more than 15 million EUR to fight coronavirus

19. March 2020
Back

Penta Investment Group will spend more than € 15 million to fight COVID-19, the new type of coronavirus.

This expenditure is already being used and will be used primarily to:

  • purchase specialized medical material and protective equipment
  • purchase COVID-19 rapid tests
  • invest immediately in healthcare facilities and pharmacies due to hospital re-profiling or technical modifications.

Penta is one of the largest investors in the healthcare sector of Central Europe. In all its medical facilities, Penta employs more than 30,000 people. Providing them with protective equipment and specialized material which is currently scarce and difficult to procure is an absolute priority for the Group.

“There is no doubt that our whole society is facing a crisis of unprecedented proportions. Our teams are working day and night in order to ensure that our medical facilities are as prepared as possible, thus enabling us to provide the best possible treatment and care for our patients,” said Jaroslav Haščák, a co-owner of Penta Group.

In the coming days and weeks, Penta is expected to import approximately 3.5 million units of protective equipment to Czech Republic and Slovakia, including the required FFP3 and FFP2 respirators. Likewise, it has also placed firm orders for and is preparing to import from China the so-called rapid tests which would enable quick testing of 100,000 people.

“We are prepared to help with rapid testing of people in full cooperation with the task force. We are able to launch the testing project across all our hospitals and clinics in order to help increase the necessary testing capacity,” said Eduard Maták, a co-owner of Penta Group responsible for healthcare.  

Penta and its healthcare companies 

Healthcare is one of the key sectors of Penta’s business, with the company having invested hundreds of millions of Euros in excess of its acquisitions in it. In Slovakia, the Group built a New Generation Hospital in Michalovce; a tertiary hospital of a new generation is currently under construction in Bratislava. Penta’s healthcare companies include Penta Hospitals International network of hospitals, Dr.Max pharmacies and Dôvera health insurance company.

More news
Penta Real Estate enters the British real estate market with two residential acquisitions

Penta Real Estate is launching its expansion into the UK property market through the development of more than 680 new apartments in two attractive locations in the wider centre of...

Petr Řehák Appointed as the New CEO and Chairman of the Board of Privatbanka

Privatbanka, a.s., a member of the Penta Investments group, has appointed Petr Řehák as Chief Executive Officer and Chairman of the Board of Directors. He replaces Ľuboš Ševčík, who is...

Penta Fund strengthens its top management

Penta is strengthening the leadership of Penta Fund. After an exceptionally successful start, experienced banker Tomáš Hochmeister will become the new CEO of Penta Fund as of December 1. He...

Fortuna Entertainment Group Acquires Montenegrin Lob

Fortuna Entertainment Group (FEG), the leading omni-channel gaming entertainment provider in Central and Eastern Europe, has signed an agreement to acquire a 51% stake in Lob, Montenegro’s second biggest operator...

Penta Hospitals plans to acquire Group Mediterra and significantly expands its healthcare network, adding six hospitals and a medical school to the network

Prague, 16 October 2025 – Penta Hospitals, one of the leading private healthcare and social care providers in Czechia, has announced the signing for the acquisition of Group Mediterra, a.s....

Penta Real Estate successfully completed the sale of Bory Mall; its new owner is the ZFP Real Estate Fund

With the successful completion of the sale of the Bory Mall shopping and entertainment center, we have reached another important milestone in our activities on the Slovak market. The transaction...

Record year for Penta, successful launch of Penta Fund

Penta has reported a record net profit of €621 million for the financial year 2024. All core portfolio companies contributed to this results, as the high level of capital investments...

Fortuna leadership update – welcoming new CEO